Objective Detect the expression of Interleukin‐6 (IL‐6) in the serum of patients with systemic
sclerosis (SSc) and assess its association with clinical and laboratory features of the …

The aim of the study is to investigate the levels of serum interleukin-35 (IL-35) before and
after treatment and its relationship with clinical parameters as well as the frequency of …

Systemic sclerosis (SSc) is a multisystem connective tissue disease characterized by three
cardinal features: immunological abnormalities, vasculopathy, and fibrosis of skin and …

Systemic sclerosis (SSc) is a complex autoimmune disease characterised by fibrosis of the
skin and multiple internal organs. Interleukin 33 (IL-33) has recently been investigated as a …

Objective To study the role of B lymphocytes in systemic sclerosis (SSc). Methods Peripheral
B cell subpopulations and the production of interleukin‐6 (IL‐6) and transforming growth …

Objectives Skin fibrosis mediated by activated dermal fibroblasts is a hallmark of systemic
sclerosis (SSc), especially in the subset of patients with diffuse disease. Transforming …

Systemic sclerosis (SSc or scleroderma) is a progressive and highly debilitating
autoimmune disorder characterized by inflammation, vasculopathy, and extensive fibrosis …

Systemic sclerosis (SSc) is a multisystemic, complex, and rare disease of connective tissue,
with high morbidity and mortality, and without specific treatment. The disease is …

Localized scleroderma (LS) is a disfiguring autoimmune disease of the skin and underlying
tissue that mainly affects the pediatric population. Inflammation of the tissue leads to fibrosis …

Studies on the role of interleukins (ILs) in autoimmune and inflammatory diseases allow for
the better understanding of pathologic mechanisms of disease and reshaping of treatment …